by Clinical Neuropsychologist Online | Friday, September 11, 2026 | Dementia
Abstract INTRODUCTION Metabolic dysfunction, altered adenosine signaling, and white matter abnormalities are implicated in tauopathies, but their relationship to network disconnection remains unclear. Myelinating oligodendrocytes may represent a metabolically...
by Clinical Neuropsychologist Online | Friday, September 11, 2026 | Dementia
Dementia, Ahead of Print. Namaste Care is a person-centered intervention for people with dementia in long-term care, particularly those in advanced stages. However, evidence on how staff are trained and supported to deliver Namaste Care remains fragmented. This...
by Clinical Neuropsychologist Online | Friday, September 11, 2026 | Dementia
Abstract INTRODUCTION The cognitive implications of longitudinal frailty exposure remain unclear. We examined associations of baseline frailty status, two-wave frailty change, and mean frailty burden with annual cognitive change and cognitive aging trajectories....
by Clinical Neuropsychologist Online | Thursday, September 10, 2026 | Dementia
Abstract INTRODUCTION Co-pathologies – including Lewy body, vascular, and TDP-43 lesions – are common in Alzheimer’s disease (AD), contributing to its clinical and pathological heterogeneity. Genetic risk factors may drive mixed pathology presentation, but their...
by Clinical Neuropsychologist Online | Wednesday, September 9, 2026 | Dementia
Abstract INTRODUCTION Blood plasma biomarkers identifying Alzheimer’s disease (AD) neuropathology offer accessible and scalable alternatives to lumbar puncture and positron emission tomography (PET) scans, with potential efficiency gains in clinical trial...
by Clinical Neuropsychologist Online | Wednesday, September 9, 2026 | Dementia
Dementia, Ahead of Print. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | September 9, 2026 Neuro-Dementia Previous...
